Brad Hunter is the Director of Immune Effector Cell Therapy and Interim Medical Director of Oncology Research at Intermountain Healthcare, where he is an Assistant Professor and member of the Bone Marrow Transplant team as LDS Hospital. He received his MD from the University of Rochester School of Medicine and Dentistry, completed Internal Medicine training at UCSF, and fellowship at the the Dana Farber Cancer Institute and Massachusetts General Hospital. His research interests include CAR T-cell therapy and the treatment of advanced hematologic malignancies. He lives in Salt Lake City and loves being close to the mountains in all seasons of the year.